Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Membrane Transport Proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Membrane Proteins (metabolism) < Membrane Transport Proteins < Membrane Transport Proteins (analysis)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000153 (1999) J E Ahlskog [États-Unis] ; R J Uitti ; M K O'Connor ; D M Maraganore ; J Y Matsumoto ; K F Stark ; M F Turk ; O L BurnettThe effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
000306 (2000) H T Benamer [Royaume-Uni] ; J. Patterson ; D J Wyper ; D M Hadley ; G J Macphee ; D G GrossetCorrelation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
000B60 (2003) Hani T S. Benamer [Royaume-Uni] ; Wolfgang H. Oertel ; Jim Patterson ; Donald M. Hadley ; Oliver Pogarell ; H. Höffken ; A. Gerstner ; Donald G. GrossetProspective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.
000C15 (2003) Stephen J. KishWhat is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
000E50 (2004) Sebastian Paus [Allemagne] ; Gert Seeger ; Hans M. Brecht ; Jürgen Köster ; Mahha El-Faddagh ; Markus M. Nöthen ; Thomas Klockgether ; Ullrich WüllnerAssociation study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
001001 (2004) William Bara-Jimenez [États-Unis] ; Tzvetelina Dimitrova ; Abdulah Sherzai ; Antonella Favit ; M M Mouradian ; Thomas N. ChaseEffect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease.
004741 (1995) P. Vieregge ; I. HeberleinNicotine consumption and Parkinson's disease--does the smoke clear up?
004D68 (1997) M. Jaber [États-Unis] ; S. Jones ; B. Giros ; M G CaronThe dopamine transporter: a crucial component regulating dopamine transmission.
004D89 (1997) D G Le Couteur [Australie] ; P W Leighton ; S J Mccann ; S M PondAssociation of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
004F18 (1998) M. Naumann [Allemagne] ; W. Pirker ; K. Reiners ; K W Lange ; G. Becker ; T. BrückeImaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.
004F56 (1998) G K Wenning [Autriche] ; E. Donnemiller ; R. Granata ; G. Riccabona ; Werner Poewe [Autriche]123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Membrane Transport Proteins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Membrane Transport Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Membrane Transport Proteins
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024